These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10952784)

  • 21. Effects of tamoxifen on human squamous cell carcinoma lines of the head and neck.
    Hoffmann TK; Bojar H; Eckel J; van Lierop A; Balz V; Friebe-Hoffmann U; Hauser U; Bier H
    Anticancer Drugs; 2002 Jun; 13(5):521-31. PubMed ID: 12045464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced expression of Wnt-1 and E-cadherin, and diminished beta-catenin stability in MCF-7 breast cancer cells that overexpress protein kinase C-alpha.
    Williams CL; Noti JD
    Int J Oncol; 2001 Dec; 19(6):1227-33. PubMed ID: 11713593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of protein kinase C delta by estrogen in the MCF-7 human breast cancer cell line.
    Shanmugam M; Krett NL; Maizels ET; Cutler RE; Peters CA; Smith LM; O'Brien ML; Park-Sarge OK; Rosen ST; Hunzicker-Dunn M
    Mol Cell Endocrinol; 1999 Feb; 148(1-2):109-18. PubMed ID: 10221776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
    Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
    Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
    Coradini D; Biffi A; Pirronello E; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice.
    Horvath G; Leser G; Helou K; Henriksson M
    Gynecol Oncol; 2002 Feb; 84(2):271-9. PubMed ID: 11812086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen.
    Boyan BD; Sylvia VL; Frambach T; Lohmann CH; Dietl J; Dean DD; Schwartz Z
    Endocrinology; 2003 May; 144(5):1812-24. PubMed ID: 12697687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.
    Brinkman A; van der Flier S; Kok EM; Dorssers LC
    J Natl Cancer Inst; 2000 Jan; 92(2):112-20. PubMed ID: 10639512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.
    Ahmad A; Ginnebaugh KR; Yin S; Bollig-Fischer A; Reddy KB; Sarkar FH
    BMC Cancer; 2015 Jul; 15():540. PubMed ID: 26206152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
    Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
    Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells.
    Nabha SM; Glaros S; Hong M; Lykkesfeldt AE; Schiff R; Osborne K; Reddy KB
    Oncogene; 2005 Apr; 24(19):3166-76. PubMed ID: 15735693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta.
    Gill PK; Gescher A; Gant TW
    Eur J Biochem; 2001 Aug; 268(15):4151-7. PubMed ID: 11488907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells.
    Sauma S; Yan Z; Ohno S; Friedman E
    Cell Growth Differ; 1996 May; 7(5):587-94. PubMed ID: 8732668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line.
    Madsen MW; Reiter BE; Lykkesfeldt AE
    Mol Cell Endocrinol; 1995 Apr; 109(2):197-207. PubMed ID: 7664983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and characterization of a 77-kDa oestrogen receptor isolated from a human breast cancer cell line.
    Pink JJ; Fritsch M; Bilimoria MM; Assikis VJ; Jordan VC
    Br J Cancer; 1997; 75(1):17-27. PubMed ID: 9000593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells.
    Soh JW; Lee YS; Weinstein IB
    J Exp Ther Oncol; 2003; 3(3):115-26. PubMed ID: 14641818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer.
    Assender JW; Gee JM; Lewis I; Ellis IO; Robertson JF; Nicholson RI
    J Clin Pathol; 2007 Nov; 60(11):1216-21. PubMed ID: 17965220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.